Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
8 Malignant disease and immunosuppression

For the most up to date list of agents funded by the Cancer Drugs Fund, please see Cancer Drug Fund list

08-01-05 Erlotinib

Erlotinib Tarceva®
  • in line with NICE and available from day 91 following publication of TA.
  • Link  NICE TA374: Lung cancer (non-small cell, locally advanced or metastatic)- erlotinib and gefitinib after prior chemotherapy
    Link  NICE TA258: Lung cancer (non small cell, EGFR-TK mutation positive) - erlotinib (1st line)
    Link  NICE TA227: Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy)

    Red View adult BNF  View SPC online  View childrens BNF  HCD